$2.08
-0.01 (-0.72%)
Corcept Therapeutics, Inc. (CORT)
CAPS Rating:
A pharmaceutical company which is engaged in the development of drugs for the treatment of severe psychiatric and metabolic diseases.

RSS Headlines
Fool UK